Mutual Matters

Carrie Lowe, JD

Recent Posts

FDA Drug Safety Communication Regarding Viberzi (eluxadoline)

Posted by Carrie Lowe, JD on Mar 30, 2017 12:30:00 PM

On March 15, 2017, the FDA issued a drug safety warning that Viberzi (eluxadoline), a drug used to treat irritable bowel syndrome with diarrhea (IBS-D), should not be used in patients who do not have a gallbladder. The FDA found that when used in patients without a gallbladder there is an increased risk of developing serious pancreatitis that could result in hospitalization or death.  Patients who are taking Viberzi (eluxadoline) who do not have a gallbladder should stop taking the drug immediately and contact their physician.

Read More

Healthcare and the New Overtime Rule

Posted by Carrie Lowe, JD on Jul 14, 2016 1:00:00 PM

Provided by Hall, Arbery, Gilligan, Roberts & Shanlever, LLP

Read More

Subscribe to Email Updates

What other resources would you like us to provide?

Sharing Insight on Mutual Matters

As one of the leading mutual providers of Medical Professional Liability insurance, we're here to help all healthcare professionals with the challenges they face on a daily basis. The topics we cover include: 

  • Healthcare legislation updates
  • Patient safety guidance
  • Practice and hospital management advice
  • and more. 

Recent Posts